Literature DB >> 6160798

Interferon production in adults with respiratory syncytial viral infection.

C B Hall, R G Douglas, R L Simons.   

Abstract

Respiratory syncytial virus may cause repeated infections and appreciable illness in adults as well as children. Factors associated with immunity and recovery are poorly understood. We studied 37 adults with natural respiratory syncytial viral illness and eight experimentally infected volunteers for nasal interferon production. Their response was compared to that of 25 adults with influenza. Interferon was detected in only six of those with natural respiratory syncytial virus and in none of those with experimental infection. The quantities of interferon were low (geometric mean, 6 U/mL) and did not appear to affect viral shedding. In contrast, 24 of influenza patients produced interferon and in greater quantities (geometric mean, 116 U/mL). This suggests that interferon is not involved in recovery from respiratory syncytial viral infection and might indicate a lack of a local cell-mediated response that could relate to the often prolonged course and shedding observed with respiratory syncytial virus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6160798     DOI: 10.7326/0003-4819-94-1-53

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Breastfeeding is associated with the production of type I interferon in infants infected with influenza virus.

Authors:  Guillermina A Melendi; Silvina Coviello; Niranjan Bhat; Johanna Zea-Hernandez; Fausto M Ferolla; Fernando P Polack
Journal:  Acta Paediatr       Date:  2010-10       Impact factor: 2.299

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 3.  Cold comfort for the catarrhal child.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

Review 4.  Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Authors:  Peter L Collins; José A Melero
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

5.  Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.

Authors:  Silvina Coviello; Vera Wimmenauer; Fernando P Polack; Pablo M Irusta
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

6.  Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity.

Authors:  C E Taylor; M S Webb; A D Milner; P D Milner; L A Morgan; R Scott; G M Stokes; A S Swarbrick; G L Toms
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

7.  A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.

Authors:  Jessica L Grieves; Zhiwei Yin; Adolfo Garcia-Sastre; Ignacio Mena; Mark E Peeples; Heidi P Risman; Hannah Federman; Marvin J Sandoval; Russell K Durbin; Joan E Durbin
Journal:  Vaccine       Date:  2018-05-18       Impact factor: 3.641

8.  Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Authors:  Nancy A Jewell; Negin Vaghefi; Sara E Mertz; Parvis Akter; R Stokes Peebles; Lauren O Bakaletz; Russell K Durbin; Emilio Flaño; Joan E Durbin
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats.

Authors:  Lioubov M Pletneva; Otto Haller; David D Porter; Gregory A Prince; Jorge C G Blanco
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

10.  Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year.

Authors:  Alayne L Bennett; David W Smith; Martin J Cummins; Peter A Jacoby; Joseph M Cummins; Manfred W Beilharz
Journal:  Influenza Other Respir Viruses       Date:  2013-02-09       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.